Strategies of Viral Vectors for Vaccine Development—2nd Edition
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Design, Development, and Delivery".
Deadline for manuscript submissions: 30 September 2026
Special Issue Editor
Interests: plant-based pharmaceuticals; public health; sustainability; molecular farming; food security
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viral vectors have been studied as innovative tools in the field of medicine. With advancements in technology, these vectors are becoming increasingly sophisticated, leading to a broader range of applications. They can be utilized to deliver therapeutic drugs, facilitate the expression of foreign proteins, and specifically target and destroy cancer cells, thereby enhancing treatment efficacy and effectiveness.
This Special Issue will center on the development and optimization of viral vectors derived from various sources, including animal, plant, and bacterial viruses. Our goal is to leverage these vectors to create safe, effective, and cost-efficient vaccines. We eagerly anticipate your valuable contributions to this exciting area of research.
Dr. Kathleen Hefferon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine
- viral vector
- virus-like particles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Strategies of Viral Vectors for Vaccine Development in Vaccines (7 articles)
